CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
The Geo Group, Vista Outdoor, CVS and Walgreens Boots Alliance highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
The Geo Group, Vista Outdoor, CVS and Walgreens Boots Alliance highlighted as Zacks Bull and Bear of the Day
Buy CVS Health (CVS) Stock After Optimistic Investor Day 2019?
by Zachary Stutler
CVS (CVS) stock jumped over 2% upon opening Tuesday morning and ended the day at $54.62, a 2.3% gain on the day. Confidence in the company???s future growth grew when it made multiple announcements regarding future earnings and projects at its investor day 2019 event.
CVS Health (CVS) Down 7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pharmacies & Drug Stores Industry Near-Term Prospects Bleak
by Urmimala Biswas
This industry is facing challenges in terms of reimbursement headwind, lower patient costs and drop in generic drug price.
The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS
Top Research Reports for Alphabet, Eli Lilly & CVS Health
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), Eli Lilly (LLY) and CVS Health (CVS).
Zacks Value Trader Highlights: Amazon, Citigroup, CVS and Lincoln National
by Zacks Equity Research
Zacks Value Trader Highlights: Amazon, Citigroup, CVS and Lincoln National
What is a Value Stock?
by Tracey Ryniec
With Berkshire Hathaway buying shares of Amazon, it's time for a refresher on what makes a stock a value.
Bull of the Day: Tabula Rasa HealthCare (TRHC)
by Kevin Cook
Exploding medical data is being harnessed by this $1.2 billion IT integrator and patient safety innovator
Company News For May 2, 2019
by Zacks Equity Research
Companies in the news are: AAPL, CVS, TAP and RCL
CVS Health (CVS) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 8.00% and 1.94%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
CVS Health's (CVS) Q1 Earnings Top Estimates, EPS View Up
by Zacks Equity Research
Year-over-year growth in CVS Health's (CVS) top line is aided by a strong Pharmacy Services segment, benefiting from the upside in specialty services.
This Week's Must-See Earnings Charts
by Tracey Ryniec
Which stocks will traders be watching this busy earnings week? These are some of those at the top of the list.
Will Pharmacy Services Drive CVS Health's (CVS) Q1 Earnings?
by Zacks Equity Research
Within Pharmacy Services, despite a fierce pricing competition, CVS Health (CVS) is currently riding on high level of service and execution, competitive pricing and a unique integrated model.
CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $52.96 in the latest trading session, marking a +1.01% move from the prior day.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $53.90, marking a -0.59% move from the previous day.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $54.18, marking a +0.22% move from the previous day.
Amazon (AMZN) Stock Looks Like a Buy Heading into Q1 2019 Earnings
by Benjamin Rains
Shares of Amazon (AMZN) have outpaced the market in 2019, up 21% against the S&P's 15% jump. Despite the strong start, Amazon stock rests over 11% below its 52-week high. So, let's take a look at why Amazon appears to be a buy right now heading into its Q1 2019 earnings release .
The Zacks Analyst Blog Highlights: Walgreens, Amazon and CVS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walgreens, Amazon and CVS
Aging Demography, Consolidation Brighten HMO Industry Outlook
by Sapna Bagaria
Increasing retirement population, industry consolidation, growth of ancillary business and easing of regulatory changes promise solid growth for the HMO industry.
What to Expect from CVS' Q1 Earnings After Walgreens Stock Tanks
by Benjamin Rains
CVS Health (CVS) stock has been down in the dumps for years and shares have already fallen 20% in 2019 even as the broader market booms. Now, after Walgreens Boots Alliance's (WBA) massive one-day, post-earnings selloff Tuesday, it's time to see what investors should expect from CVS.
Walgreens Has Biggest One-Day Loss in 5 year: What Does This Mean For Pharmacies?
by Daniel Laboe
Walgreens Boots Alliance (WBA) dropped over 12% today taking the price down to a low of $55, the lowest the stock has traded at since 2014. WBA???s tumble was initiated by worse than expected earnings, and a full year EPS guidance adjustment which would make them flat for 2019.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $54.19, marking a +0.48% move from the previous day.
Buy Walgreens (WBA) Stock Ahead of Q2 Earnings, Before CBD Push?
by Benjamin Rains
Shares of Walgreens Boots Alliance, Inc. (WBA) have fallen roughly 9% this year, which stands in contrast to the market's nearly 13% climb and its industry's 4.5% average gains. But is it time to buy WBA stock ahead of earnings?